However, S. aureus do possess terminal complement inhibitors such as SSL739,40 indicating a role for blocking MAC activity, and humans with deficiencies in early complement components (e.g., C1q, C2, C3, C4) are susceptible to multiple bacterial infections including S. aureus41. The gene discussed is C4A; the disease is bacterial infectious disease.